摘要
细胞竞争是首次发现四十年前作为一种机制来消除在果蝇不适合的细胞,在研究过程中,后来又假设参与人类的肿瘤的产生。然而,在哺乳动物肿瘤中类似的机制证据被错过了,直到最近几年才被发现。像在苍蝇中的细胞竞争,多种形式的竞争机制是在哺乳动物系统被报告,其中一些被发现参与肿瘤的起始。最近,一种机制entosis,食细胞的cell-in-cell结构在人类肿瘤的形成,被认定为新型的不断扩大的家庭成员的哺乳动物细胞竞争中(MaCCs),并提出能够促进克隆选择和肿瘤的进化。因此,吞没周边细胞以外的其他特殊的吞噬细胞,苍蝇的一个问题仍在辩论中,显然是负责消除在哺乳动物的失败者。竞争机制由cell-in-cell结构,由多个“食人魔”机制,构成了新型的MaCCs类。本文将总结目前研究哺乳动物细胞竞争,其次是功能和机理分析及其对人类肿瘤潜在影响的病理和治疗。
关键词: Cell competition
Current Molecular Medicine
Title:Mammalian Cell Competitions, Cell-in-Cell Phenomena and Their Biomedical Implications.
Volume: 15 Issue: 9
Author(s): H. Huang, Z. Chen and Q. Sun
Affiliation:
关键词: Cell competition
摘要: Cell competition was first identified four decades ago as a mechanism to eliminate less fit cells during development in Drosophila melanogaster, and later postulated to be involved in tumorigenesis of human beings. However, evidence for a similar mechanism functional in mammals and tumors was missed until recent years. Like cell competition in fly, multiple forms of competition mechanisms were reported in mammalian system, and some of them were found participating in tumor initiation. Lately, entosis, a mechanism of cell cannibalisms responsible for the formation of cell-in-cell structures in human tumors, was identified as a novel member of ever-expanding family of mammalian cell competitions (MaCCs), and proposed to be able to promote clonal selection and tumor evolution. Thus, engulfment by neighboring cells other than the professional phagocytes, an issue still in debate in fly, was clearly demonstrated in mammals to be responsible for loser elimination. Competition mediated by cell-in-cell structures, formed by multiple cannibal mechanisms, constitutes a novel class of MaCCs. This review will summarize current research on mammalian cell competitions, followed by feature and mechanism analysis and their potential implications in the pathology and treatment of human tumors.
Export Options
About this article
Cite this article as:
H. Huang, Z. Chen and Q. Sun , Mammalian Cell Competitions, Cell-in-Cell Phenomena and Their Biomedical Implications., Current Molecular Medicine 2015; 15 (9) . https://dx.doi.org/10.2174/1566524015666151026101101
DOI https://dx.doi.org/10.2174/1566524015666151026101101 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
CRISPR-Cas9, A Promising Therapeutic Tool for Cancer Therapy: A Review
Protein & Peptide Letters Potentials and Challenges of Active Targeting at the Tumor Cells by Engineered Polymeric Nanoparticles
Current Pharmaceutical Biotechnology Histone Deacetylase Inhibitors as Potential Therapeutic Agents for the Treatment of Malignant Mesothelioma
Anti-Cancer Agents in Medicinal Chemistry Scintigraphic Imaging of Inflammatory Processes
Medicinal Chemistry Reviews - Online (Discontinued) The Role of Chronic Periodontitis in Prevention and Treatment of Head and Neck Cancers
Current Cancer Therapy Reviews Altered Hyaluronan Biosynthesis and Cancer Progression: an Immunological Perspective
Mini-Reviews in Medicinal Chemistry Current Prospects of Synthetic Curcumin Analogs and Chalcone Derivatives Against Mycobacterium Tuberculosis
Medicinal Chemistry An Overview of Targeted Alpha Therapy with <sup>225</sup>Actinium and <sup>213</sup>Bismuth
Current Radiopharmaceuticals Importance of Wnt Signaling in the Tumor Stroma Microenvironment
Current Cancer Drug Targets Targeting of Peptide Cytotoxins to LHRH Receptors For Treatment of Cancer
Current Drug Targets Application of Bacterial Nanocellulose in Cancer Drug Delivery: A Review
Current Pharmaceutical Design PepT1, ASBT-Linked Prodrug Strategy to Improve Oral Bioavailability and Tissue Targeting Distribution
Current Drug Metabolism Cdc20: A Potential Novel Therapeutic Target for Cancer Treatment
Current Pharmaceutical Design Pleiotrophin as a Possible New Target for Angiogenesis-Related Diseases and Cancer
Recent Patents on Anti-Cancer Drug Discovery Process Variables and Design of Experiments in Liposome and Nanoliposome Research
Mini-Reviews in Medicinal Chemistry Editorial Review 2017
Current Radiopharmaceuticals Diethyldithiocarbamate complex with copper: the mechanism of action in cancer cells
Mini-Reviews in Medicinal Chemistry The Role of Cytochrome P450 in Cytotoxic Bioactivation: Future Therapeutic Directions
Current Cancer Drug Targets Applications of the Rare Earth Elements in Cancer Imaging and Therapy
Current Nanoscience Fluorescent Cisplatin Analogues and Cytotoxic Activity
Current Medicinal Chemistry